| Does gut hormone PYY3–36 decrease food intake in rodents? M Tschöp, TR Castaneda, HG Joost, C Thöne-Reineke, S Ortmann, ... Nature 430 (6996), 1-3, 2004 | 257 | 2004 |
| SAKK 16/14: durvalumab in addition to neoadjuvant chemotherapy in patients with stage IIIA (N2) non–small-cell lung cancer—a multicenter single-arm phase II trial SI Rothschild, A Zippelius, EI Eboulet, S Savic Prince, D Betticher, ... Journal of clinical oncology 39 (26), 2872-2880, 2021 | 199 | 2021 |
| PYY3‐36 as an anti‐obesity drug target MM Boggiano, PC Chandler, KD Oswald, RJ Rodgers, JE Blundell, Y Ishii, ... obesity reviews 6 (4), 307-322, 2005 | 151 | 2005 |
| The influence of two different hydroxyethyl starch solutions (6% HES 130/0.4 and 200/0.5) on blood viscosity TA Neff, L Fischler, M Mark, R Stocker, WH Reinhart Anesthesia & Analgesia 100 (6), 1773-1780, 2005 | 110 | 2005 |
| Thiols and pancreatic β‐cell function: A review HPT Ammon, M Mark Cell Biochemistry and Function: Cellular biochemistry and its modulation by …, 1985 | 92 | 1985 |
| Clinical outcome of ALK-positive non–small cell lung cancer (NSCLC) patients with De Novo EGFR or KRAS co-mutations receiving tyrosine kinase inhibitors (TKIs) S Schmid, O Gautschi, S Rothschild, M Mark, P Froesch, D Klingbiel, ... Journal of Thoracic Oncology 12 (4), 681-688, 2017 | 69 | 2017 |
| Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivors AJ Templeton, B Thürlimann, M Baumann, M Mark, S Stoll, M Schwizer, ... BMC cancer 13, 1-8, 2013 | 64 | 2013 |
| Physiology: Does gut hormone PYY 36 decrease food intake in rodents? M Tschop, TR Castaneda, HG Joost, C Thone-Reineke, S Ortmann, ... Nature 430 (6996), 165, 2004 | 58 | 2004 |
| SAKK 16/14: Anti-PD-L1 antibody durvalumab in addition to neoadjuvant chemotherapy in patients with stage IIIA (N2) non-small cell lung cancer (NSCLC)—A multicenter single-arm … S Rothschild, A Zippelius, EI Eboulet, S Savic, DC Betticher, A Bettini, ... J Clin Oncol 38 (suppl 15), 9016, 2020 | 49 | 2020 |
| A randomized open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC: the European Thoracic Oncology Platform (ETOP … S Peters, S Danson, B Hasan, U Dafni, N Reinmuth, M Majem, ... Journal of Thoracic Oncology 15 (10), 1647-1656, 2020 | 36 | 2020 |
| Commercial taxane formulations induce stomatocytosis and increase blood viscosity M Mark, R Walter, DO Meredith, WH Reinhart British journal of pharmacology 134 (6), 1207-1214, 2001 | 34 | 2001 |
| Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors A Stathis, D Hess, R von Moos, K Homicsko, G Griguolo, M Joerger, ... Investigational new drugs 35, 766-772, 2017 | 33 | 2017 |
| Gastrointestinal motility modulation with Iberogast SN Okpanyi, M Mark, MA Wahl WOCMAP I-Medicinal and Aromatic Plants Conference: part 2 of 4 332, 227-236, 1992 | 33 | 1992 |
| Pharmacological concentrations of arginine influence human whole blood viscosity independent of nitric oxide synthase activity in vitro R Walter, M Mark, WH Reinhart Biochemical and biophysical research communications 269 (3), 687-691, 2000 | 31 | 2000 |
| Lurbinectedin as second-or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16) Y Metaxas, M Früh, EI Eboulet, F Grosso, M Pless, PA Zucali, GL Ceresoli, ... Annals of Oncology 31 (4), 495-500, 2020 | 30 | 2020 |
| The effect of glucose on insulin release and ion movements in isolated pancreatic islets of rats in old age. HP Ammon, A Fahmy, M Mark, MA Wahl, N Youssif The Journal of Physiology 384 (1), 347-354, 1987 | 30 | 1987 |
| Impact of addition of metformin to abiraterone in metastatic castration-resistant prostate cancer patients with disease progressing while receiving abiraterone treatment (MetAb … M Mark, D Klingbiel, U Mey, R Winterhalder, C Rothermundt, S Gillessen, ... Clinical genitourinary cancer 17 (2), e323-e328, 2019 | 27 | 2019 |
| Impact of early prophylactic cranial irradiation with hippocampal avoidance on neurocognitive function in patients with limited disease small cell lung cancer. A multicenter … H Vees, F Caparrotti, EI Eboulet, A Xyrafas, A Fuhrer, U Meier, M Mark, ... International Journal of Radiation Oncology* Biology* Physics 107 (2), 279-287, 2020 | 25 | 2020 |
| Multimodal treatment in operable stage III NSCLC: a pooled analysis on long-term results of three SAKK trials (SAKK 16/96, 16/00, and 16/01) M Früh, DC Betticher, R Stupp, A Xyrafas, S Peters, HB Ris, ... Journal of thoracic oncology 14 (1), 115-123, 2019 | 23 | 2019 |
| Failure of glucose to affect 86rubidium efflux and 45calcium uptake of fetal rat pancreatic islets. HP Ammon, A Fahmy, M Mark, W Strölin, MA Wahl The Journal of Physiology 358 (1), 365-372, 1985 | 23 | 1985 |
